Skip to content

Free cash flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$816M+126%
IQVIA logo
IQVIAIQV
$491M+15.3%
Medline, Inc.
 logo
Medline, Inc. MDLN
$316M-45.9%
Labcorp Holdings logo
Labcorp HoldingsLH
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
Tenet Healthcare logo
Tenet HealthcareTHC

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Calculated from Medpace Holdings, Inc.’s reported figures.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s free cash flow?
Medpace Holdings, Inc. (MEDP) reported free cash flow of $144.97M in Q1 2026.
How has Medpace Holdings, Inc.'s free cash flow changed year-over-year?
Medpace Holdings, Inc.'s free cash flow increased by 25.1% year-over-year, from $115.84M to $144.97M.
What is the long-term trend for Medpace Holdings, Inc.'s free cash flow?
Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s free cash flow has grown at a 30.5% compound annual growth rate (CAGR), from $235.06M to $681.87M.